What is NDC 63736-020?

63736-020 is the product NDC for Monistat Maintain (phenazopyridine hydrochloride), Phenazopyridine hydrochloride 99.5 mg/1 tablet, listed with the FDA by Insight Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Monistat Maintain (Phenazopyridine hydrochloride).

Insight Pharmaceuticals LLC, NDC labeler code 63736. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Monistat Maintain?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Monistat Maintain NDC 63736-020 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63736-020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63736-0020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63736-020-12	6373600201263736002012	1 BLISTER PACK in 1 CARTON (63736-020-12) / 12 TABLET in 1 BLISTER PACKMarketed from Mar 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Monistat Maintain
Generic name (nonproprietary): phenazopyridine hydrochloride
Active ingredients: Phenazopyridine hydrochloride — 99.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Insight Pharmaceuticals LLCNDC labeler code 63736
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: Mar 1, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 63736-020_e114e8a0-7f90-4363-8d44-eacb4bce5df7SPL ID e114e8a0-7f90-4363-8d44-eacb4bce5df7SPL set ID d1e563fc-5a91-4867-8177-93102bd24fe4RxCUI 1094147UNII 0EWG668W17

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463736002012 followed by a unit qualifier and the quantity

Package 63736-0020-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 23, 2025.

Indications (excerpt from the label)

Use fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63736-020

What is NDC 63736-020?: 63736-020 is the product NDC for Monistat Maintain (phenazopyridine hydrochloride), Phenazopyridine hydrochloride 99.5 mg/1 tablet, listed with the FDA by Insight Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Monistat Maintain (Phenazopyridine hydrochloride).
What is the active ingredient?: Phenazopyridine hydrochloride.
Who is the labeler?: Insight Pharmaceuticals LLC, NDC labeler code 63736. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Monistat Maintain?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Monistat Maintain (Phenazopyridine hydrochloride) NDC 63736-020